RESIST-TB will host a webinar, LAM (lipoarabinomannan) as a pharmacodynamic biomarker and drug development tool for TB, on 22 June 2017 from 08:30 to 09:30 EST (14:30-15:30 CEST, SAST).
For more information about the webinar and how to connect, click here.